IQVIA Holdings, Inc. (IQV) Earnings

IQVIA Holdings, Inc.

IQV · NYSE

Sep 2026upcoming

Next quarter

Consensus is $2.94 EPS for Sep 2026 across 6 estimates, ranging $2.88 to $3.00.

IQV Jun 2026

Reported Jul 28, 2026

Beat 1.10%

EPS estimate: $2.72
EPS actual: $2.75
Revenue estimate: —
Revenue actual: —
1-day move: +1.90%

Call highlights have not been generated for this quarter.

Symbol: IQV
Type: Stock
Sector: Health Care
Industry: Biotechnology: Commercial Physical & Biological Resarch
Country: North America
Exchange: NYSE

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA's portfolio of solutions are powered by IQVIA Connected Intelligence to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry.

Key Issues

Bullish view

Record bookings of $3.15 billion and the second-quarter earnings beat support the view that demand is strengthening. Higher 2026 guidance indicates management expects backlog conversion to translate into improved results.

Bearish view

The stock declined after the earnings-related advance, leaving execution and backlog conversion as unresolved concerns. The reported bookings record does not guarantee timely revenue growth or sustained gains.

Analyst Consensus

See all

Buy

17 analysts

$238

Current

—

Low

$275

Average

—

High

Average target implies +15.52% versus the current price.

Earnings History

BeatMissNo estimate

Peers

Waters CorporationWAT · NYSE$400.98